182 related articles for article (PubMed ID: 37986103)
1. m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling.
Wang X; Liu Y; Zhou M; Yu L; Si Z
J Exp Clin Cancer Res; 2023 Nov; 42(1):306. PubMed ID: 37986103
[TBL] [Abstract][Full Text] [Related]
2. TUFT1 Facilitates Metastasis, Stemness, and Vincristine Resistance in Colorectal Cancer via Activation of PI3K/AKT Pathway.
Yang Y; Zhang T; Wu L
Biochem Genet; 2021 Aug; 59(4):1018-1032. PubMed ID: 33634374
[TBL] [Abstract][Full Text] [Related]
3. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
4. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
[TBL] [Abstract][Full Text] [Related]
5. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
7. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract][Full Text] [Related]
8. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
9. Up regulation of long non-coding RNAs BACE1 and down regulation of LINC-PINT are associated with CRC clinicopathological characteristics.
Bakhtiari-Nezhad S; Rejali L; Hadizadeh M; Taleghani MY; Aghdaei HA; Young C; Khanabadi B; Nazemalhosseini-Mojarad E; Bonab MA
Mol Biol Rep; 2022 Nov; 49(11):10259-10267. PubMed ID: 36087249
[TBL] [Abstract][Full Text] [Related]
10. m
Zeng W; Zhu JF; Guo J; Huang GJ; Ai LS; Zeng Y; Liao WJ
Cell Death Dis; 2022 Nov; 13(11):1008. PubMed ID: 36446779
[TBL] [Abstract][Full Text] [Related]
11. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
Chang S; Sun G; Zhang D; Li Q; Qian H
Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
[TBL] [Abstract][Full Text] [Related]
12. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
13. The N
Lin C; Ma M; Zhang Y; Li L; Long F; Xie C; Xiao H; Liu T; Tian B; Yang K; Guo Y; Chen M; Chou J; Gong N; Li X; Hu G
Mol Cancer; 2022 Mar; 21(1):80. PubMed ID: 35305647
[TBL] [Abstract][Full Text] [Related]
14. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
16. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca
Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K
Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
[TBL] [Abstract][Full Text] [Related]
19. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.
Jiang Z; Hou Z; Liu W; Yu Z; Liang Z; Chen S
Bioengineered; 2022 Jan; 13(1):810-823. PubMed ID: 34974791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
